Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
PHASE2CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
August 31, 2004
Primary Completion Date
April 30, 2006
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG
dexamethasone
DRUG
doxorubicin hydrochloride
DRUG
thalidomide
DRUG
vincristine sulfate
Trial Locations (1)
14263-0001
Roswell Park Cancer Institute, Buffalo
All Listed Sponsors
lead
Roswell Park Cancer Institute
OTHER
NCT00054158 - Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma | Biotech Hunter | Biotech Hunter